News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor (World)
GlaxoSmithKline (GSK) CEO Confident Investors Will Be Pleased With Pipeline on Nov. R&D Day 7/30/2015
Zealand Pharma  (ZEAL.CO) Release: Major Shareholder Announcement 7/30/2015
Tissue Therapies Change In Strategy And Development Of Vitrogro As A Pharmaceutical Worldwide 7/28/2015
ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting 7/27/2015
Deutsche Biotech Innovativ AG: AGM Approves Bonus Shares And Capital Increase 7/24/2015
BioLight Announces Upcoming Change Of ADS Conversion Ratio 7/23/2015
Integrity Applications, Inc. Announces Adjournment Of Annual Meeting 7/23/2015
Allergy Therapeutics plc: Notice of Results and Trading Update 7/23/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 7/22/2015
NeuroDerm (NDRM) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015
Horizon Pharma (HZNP) Increases Offer For Depomed (DEPO) To $33.00 Per Share 7/21/2015
Secondary Placing Of Ordinary Shares In ErgoMed 7/20/2015
NOVACYT Release: Strong First-Half Revenues Completes €3.5 Million In Bond Refinancing And Launches A €1.7 Million Private Placement 7/20/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 7/17/2015
Chiasma Prices Initial Public Offering Of Common Stock 7/16/2015
NeuroDerm (NDRM) Announces Pricing Of Public Offering 7/16/2015
ProNAi Therapeutics, Inc. Announces Pricing Of Initial Public Offering 7/16/2015
MediGene AG (MDGEF.PK): Notification § 27a 7/15/2015
RedHill Biopharma Ltd. (RDHL) Announces Size Of Proposed Public Offering Of Its American Depository Shares 7/15/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 7/15/2015
Amarantus BioSciences, Inc. To Commence Trading On The OTCQX Marketplace Under Existing Ticker Symbol AMBS 7/13/2015
Concordia Healthcare (CXR.TO) Announces Filing of Preliminary Base Shelf Prospectus 7/13/2015
Merus Labs International Inc. Announces Filing of Preliminary Base Shelf Prospectus 7/10/2015
EXCLUSIVE: New Report Says Biosimilars Will Earn $55B by 2020, As Pfizer (PFE), Actavis (ACT), AbbVie (ABBV) Claim U.S. Market 7/9/2015
Shareholders Support Management Proposals At SYGNIS ' AGM With Large Majority 7/9/2015
Karolinska Development AB Implements A More Prudent And Representative Approach To Reporting The Fair Value Of Its Portfolio - Divestment Of Pharmanest 7/9/2015
Karolinska Development AB Divests Its Holding In Pharmanest To An Investment Consortium Comprising Östersjöstiftelsen, Recipharm Venture Fund And Praktikerinvest 7/9/2015
Prima Biomed (PRR.AX) Announces Share Purchase Plan 7/8/2015
Resverlogix (RVX.TO) Closes License Agreement And Enters Into Definitive Stock Purchase Agreement With Shenzhen Hepalink Pharmaceutical Co., Ltd 7/8/2015
NeuroDerm (NDRM) Files Registration Statement For Proposed Follow-On Offering 7/6/2015
Cortendo Provides 2015 Half-Year Update On Corporate Progress 7/2/2015
BiondVax Pharmaceuticals To Close Trading On NASDAQ On July 10, 2015 7/2/2015
EXCLUSIVE: Gene Therapy M&A Booms, Increasing 40-Fold to $4.9 Billion 7/1/2015
Conversion Right Extended On Opko Health (OPK) 3.0% Convertible Senior Notes 7/1/2015
Resverlogix (RVX.TO) Shareholders Approve Matters Relating To Licensing And Equity Arrangement 7/1/2015
Number Of Shares And Votes In Orexo AB (ORXOF) 6/30/2015
BrainStorm Cell Therapeutics Inc. Added To Russell Microcap Index 6/29/2015
Concordia Healthcare Corp. Reports Results Of Annual General Meeting Of Shareholders 6/26/2015
Pluristem Therapeutics (PSTI) Announces Pricing Of Registered Direct Offering Of Common Stock And Warrants 6/25/2015
Endo International (ENDP) Announces Pricing Of Private Offering Of Senior Notes 6/24/2015
Medigus (MDGS.TA) - ADR Free Issuance Announcement 6/24/2015
Highland Therapeutics Announces Closing Of US$50 Million Financing 6/24/2015
Celyad Announces Closing of Its Global Offering 6/24/2015
BiondVax Pharmaceuticals Announces A Closing Of Over-Allotment Option 6/24/2015
Pharmascience Inc. To Invest More Than $55 Million To Upgrade Its R&D And Manufacturing Facilities In Greater Montreal 6/22/2015
Galapagos (GLPG.BR) Raises €4.4 Million Through Warrant Exercises 6/22/2015
Endo International (ENDP) Announces Proposed Private Offering Of Senior Notes 6/19/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
CytoTools And Existing Shareholders Strengthen Successful Subsidiary Dermatools Biotech Gmbh With Capital Increase 6/17/2015
Atopix Secures Funding To Broaden Development Of CRTH2 Antagonists For TH2-Mediated Disease 6/17/2015
Axovant (AXON) Announces Completion Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/16/2015
BioTie Therapies Corp. Announces Closing Of U.S. Public Offering And Conversion Of Convertible Notes 6/16/2015
Intellirod Spine Raises Capital And Obtains ISO Certification 6/16/2015
Cellular Biomedicine Group (CBMG) Selected For Inclusion In The Russell 3000 Index 6/16/2015
Zealand Pharma  (ZEAL.CO) Release: Major Shareholder Announcement 6/15/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Voting Results From Its Annual Meeting Of Shareholders 6/15/2015
ProNAi Therapeutics, Inc. Files Registration Statement For Proposed Initial Public Offering 6/15/2015
Enzymotec Announces Annual General Meeting Of Shareholders 6/12/2015
BioAtla Receives $30 Million Equity Investment From China-based Investor Group 6/11/2015
Aptose Biosciences Announces Results Of Annual And Special Meeting Of Shareholders 6/11/2015
Endo International (ENDP) Closes Offering Of 27,627,628 Ordinary Shares 6/11/2015
Oramed Pharmaceuticals Inc. (ORMP) Announces Closing Of $5.36 Million Registered Direct Offering 6/11/2015
Amarantus BioSciences, Inc. Completes Capital Restructuring In Preparation For National Exchange Listing 6/10/2015
China Biologic Products Announces Pricing Of Public Offering Of Common Stock 6/10/2015
Resolutions Of The Annual General Meeting Of Evotec AG (EVTG.F) 6/9/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Details Of 2015 Annual Meeting Of Shareholders 6/5/2015
Oramed Pharmaceuticals Inc. (ORMP) To Raise $5.36 Million In Registered Direct Offering 6/5/2015
Endo International (ENDP) Prices Offering Of 24,024,025 Ordinary Shares 6/5/2015
Ipsen (IPN.PA) Initiates A Share Buyback Program 6/3/2015
Zealand Pharma  (ZEAL.CO) Increases The Share Capital After Exercise Of Employee Warrants And Announces An Amendment To Its Articles Of Association 6/2/2015
NeuroDerm (NDRM) To Ring The Nasdaq Stock Market Opening Bell On June 3, 2015 6/2/2015
Merus Labs International Inc. Announces Closing Of Exercise Of Over-Allotment Option 6/1/2015
Number Of Shares And Votes In Orexo AB (ORXOF) 5/29/2015
Combined Shareholders’ Meeting Of IPSEN S.A. Held On 27 May 2015 5/29/2015
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself 5/28/2015
Aurinia (ISA.TO) Announces Results Of Annual General Meeting 5/28/2015
Israeli Biotech Company Vaxil Bio To List On Toronto Stock Exchange Venture Through Reverse Takeover With Emerge Resources 5/27/2015
Tianyin Pharmaceutical Co, Inc. Adjourned Its 2014 Annual Shareholder Meeting And Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 5/27/2015
Resolutions Adopted By The Extraordinary General Meeting In Karo Bio AB Held On May 25, 2015 5/26/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 5/26/2015
Valeant (VRX) Announces 2015 Annual Meeting Results 5/20/2015
Portage Biotech Announces Proposed Private Placement 5/20/2015
BioInvent (BOVNF): BioInvent’s Rights Issue Oversubscribed 5/18/2015
GW Pharma (GWPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional American Depositary Shares 5/18/2015
Onxeo: Publication Of A Letter To Shareholders – May 2015 5/13/2015
Report From The 2015 Annual General Meeting In Aerocrine 5/13/2015
Valeant (VRX) To Webcast 2015 Annual Meeting Of Shareholders 5/13/2015
Skyepharma PLC (SKYEF) AGM Trading Update 5/12/2015
Golden Meditech Proposes To Purchase CCBC Convertible Notes Held By Magnum And CCBC Convertible Notes And CCBC Shares Held By CGL 5/8/2015
China Cord Blood Corporation Receives Notice Of Transactions Regarding Its 7% Senior Convertible Notes Due 2017 Held By Cordlife And Magnum And Its Ordinary Shares Held By CordLife Ltd. 5/8/2015
GENFIT (ALGFT) Announces Its Turnover And Cash Situation As Of March 31, 2015 5/7/2015
Affimed Therapeutics AG (AFMD) Announces Pricing Of Public Offering Of Common Stock 5/7/2015
Galapagos (GLPG.BR) Listed 10 Years On Euronext Amsterdam And Brussels 5/6/2015
Galapagos (GLPG.BR) Announces Launch Of Proposed Global Offering 5/6/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Cardio3 Biosciences Announces Results Of Annual Shareholder Assembly 2015 And Confirmation Of Name Change To Celyad 5/5/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
Macrocure (MCUR) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
Tikcro Technologies Files Annual Report On Form 20-F For The Year Ended December 31, 2014 5/4/2015
China Cord Blood Corporation Receives Notice Of A Transaction Regarding Its 7% Senior Convertible Notes Due 2017 Held By KKR 5/4/2015
WuXi PharmaTech Co., Ltd. Announces Receipt Of Proposal 5/1/2015
WuXi PharmaTech Co., Ltd. Receives $3.2 Billion Privatization Offer 4/30/2015
Basilea Pharmaceutica (BSLN.SW) Shareholders Approve All Resolutions Proposed By The Board Of Directors At The Ordinary General Meeting Of Shareholders 4/29/2015
Sobi's Board Of Directors Postpones Annual General Meeting Of Shareholders 4/29/2015
ProQR Therapeutics B.V. (PRQR) Announces Annual Shareholder Meeting 4/29/2015
NeuroDerm Ltd. (NDRM) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 4/29/2015
Novogen Limited (NVGN) Completes The Private Placement Of Equity 4/29/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Extension To Regain Compliance With Nasdaq's Minimum Bid Price Rule 4/29/2015
Sinovac Biotech Ltd. (SVA) Files 2014 Annual Report On Form 20-F 4/29/2015
Precise Biometrics AB: Resolutions At Precise Biometrics´ Annual General Meeting 2015 4/28/2015
ERYtech Pharma Receives The EnterNext Tech 40 Label 4/28/2015
Syngenta AG (SYT) Annual General Meeting 4/28/2015
Novogen Limited (NVGN) Regains Full Compliance With NASDAQ Listing Rule 4/28/2015
China Cord Blood Corporation Receives $512 Million Take-Private Offer 4/28/2015
GW Pharmaceuticals (GWPH) Announces Proposed Public Offering Of ADSs 4/28/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/27/2015
Nordic Nanovector – Share Capital Increase Registered 4/24/2015
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering 4/24/2015
Horizon Pharma (HZNP) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015
The Nomination Committee’s Proposals To The Annual General Meeting In Karo Bio AB 4/23/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 4/23/2015
Change In BioTie Therapies Corp.' Financial Calendar 2015 4/23/2015
Annual General Meeting In BioInvent (BOVNF) 4/22/2015
Tiziana Life Sciences Plc Release: Issue Of Convertible Loan Notes And Warrants 4/22/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares 4/20/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/17/2015
Admedus Completes Fully Subscribed $16.1 Million Rights Issue 4/17/2015
Nuvo Research Inc. (NRI.TO) Updates Company Strategy 4/16/2015
WuXi PharmaTech Co., Ltd. Files 2014 Annual Report On Form 20-F 4/15/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 4/15/2015
Cellular Biomedicine Group (CBMG) Upgraded To NASDAQ Global Market 4/10/2015
uniQure (QURE) Announces Pricing Of Follow-On Public Offering 4/10/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
“Batten Down the Hatches” But Look For Opportunity in Rough First Quarter, Says Analyst 4/8/2015
Lonza Group Ltd. (LZAGY.PK) Announces Results Of Annual General Meeting Annual General Meeting Accepts All Motions Proposed By Board Of Directors 4/8/2015
Prothena (PRTA) Announces Pricing Of Public Offering Of 3,300,000 Ordinary Shares 4/8/2015
Replicel Life Sciences Receives TSX Venture Exchange Approval To Extend Warrant Expiry Dates 4/8/2015
Prothena (PRTA) Announces Proposed Offering of Ordinary Shares 4/7/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets 4/6/2015
Mallinckrodt (MNK) Launches Notes Offering 4/6/2015
WuXi PharmaTech Co., Ltd. Lists Shares Of Small-Molecule Manufacturing Subsidiary STA On New Third Board In China 4/3/2015
Amgen (AMGN) in the Crosshairs As Biogen (BIIB), Hospira, Merck & Co. (MRK) All Climb on Biosimilar Bandwagon: Citi 4/2/2015
BTG plc (BTG.L): Close Period Update 4/2/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Files Registration Statement For Proposed Follow-On Offering 4/2/2015
Salix (SLXP) Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes And Merger Event Relating To Its 1.5% Convertible Senior Notes Due 2019 4/2/2015
Trinity Biotech plc Announces Proposed Offering Of $100 Million Of Exchangeable Senior Notes Due 2045 4/2/2015
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States 4/1/2015
Trillium Therapeutics Inc. Announces Pricing Of Public Offering Of Securities 4/1/2015
Valeant (VRX) Completes Tender Offer For Salix (SLXP) 4/1/2015
NeuroVive Pharmaceutical AB (publ) - Amendment Number Of Shares And Votes 3/31/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/30/2015
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015
Covalon Technologies Ltd. Announces Issuance Of Stock Options 3/30/2015
Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB) 3/30/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company 3/27/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign 3/27/2015
BioPharm Executive: Why Your Last Investment Blew Up 3/26/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/25/2015
Notice of General Meeting In Probi AB (publ) 3/25/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY) 3/23/2015
Notice Of Annual General Meeting In Bioinvent International AB 3/23/2015
Convening Notice For 2015 Annual General Meeting In Precise Biometrics AB (Publ) 3/23/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/20/2015
TiGenix: Convening Notice To The Annual And The Extraordinary Shareholders' Meeting To Be Held On 20 April 2015 3/20/2015
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015
Admedus Announces Placement And Rights Issue 3/18/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst 3/17/2015
Valeant (VRX) Announces Offering Of $1.45 Billion Of Common Shares 3/17/2015
Valeant (VRX) Prices Offering Of $1.45 Billion Of Common Shares 3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS 3/16/2015
Ablynx (ABLYF) Announces Warrant Exercise 3/16/2015
Notice of Annual General Meeting Of Orexo AB (ORXOF) 3/16/2015
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 3/16/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 3/16/2015
Polar Capital Funds Plc And Fmr Llc Provide Notification Of Shareholding In Ablynx (ABLYF) 3/16/2015
ThromboGenics NV (TBGNF) Full Year 2014 Business Update 3/13/2015
Actavis (ACT) Announces Closing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/12/2015
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise And Projection Of Improved Cash Position At The End Of 2015 3/12/2015
Replicel Life Sciences In Japan For Key Industry Meetings 3/12/2015
SYGNIS To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015
Lonza Group Ltd. (LZAGY.PK) Publishes Annual Report 2014 And Invitation To The 2015 Annual General Meeting 3/11/2015
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 3/10/2015
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst 3/6/2015
PhytoTech Medical Limited (ASX:PYL) Investor Presentation 3/6/2015
Galapagos NV (GLPG.BR) To Be Included In Amsterdam Midcap Index 3/6/2015
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib 3/5/2015
Neovacs SA Scientific Advisory Board Endorses Company's Updated IFNa-Kinoid Development Plan 3/4/2015
Actavis (ACT) Announces Pricing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/4/2015
Aviva Plc And Aviva Investors Global Services Limited Provide Notification Of A 5.02% Shareholding In Ablynx (ABLYF) 3/3/2015
Mylan Inc. (MYL) Files Annual Report On Form 10-K For Year Ended Dec. 31, 2014 3/3/2015
Actavis (ACT) Announces Closing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 3/3/2015
InMed To Present Investor Webcast March 5 3/2/2015



//-->